Discovering and developing innovative therapeutics for CNS disorders

Welcome to the Newron Pharmaceuticals website.
We are a clinical-stage biopharmaceutical company. Our shares are listed on the SWX Swiss Exchange (NWRN). Our mission is to discover, develop and commercialise novel drugs to treat diseases of the Central Nervous System (CNS) and pain.

Research & Drug Development

RLS

Restless Leg Syndrome

RLS, a common, but often misdiagnosed or underdiagnosed, sleep movement disorder which is characterised by a distressing urge to move the legs and sometimes also other body parts, usually accompanied by a marked sense of discomfort or pain in the legs. RLS is typically triggered by rest or inactivity and its symptoms are temporarily relieved or suppressed by movement.  The urge to move the legs is accompanied by unpleasant sensations in the lower extremities.  These unpleasant sensations can be burning, creeping, tugging or tingling inside the legs, ranging from being uncomfortable to painful.  The symptoms begin to worsen during periods of inactivity, particularly at night, and interfere with sleep. The particular mechanism triggering RLS is not currently known. Recent research suggests that it affects about 10% of adults in North America and Europe (National Sleep Foundation, US, 2003).